Coronavirus pharma news roundup – 03/07/20
Macro Briefing | 3 July 2020
Coronavirus: theatres are already closing – the UK government needs to act now
China A50 Index soars on rate cuts and upbeat PMIs!
Decline of the English pub: coronavirus compounded the industry's problems
Forex Weekly Look Back: FXSpotStream reports third highest ADV month ever, BDSwiss secures FSA Seychelles license
U.S. reports 55,000 COVID-19 cases in single day, hits new global record
Regeneron, Sanofi arthritis drug fails COVID-19 study
COVID-19 vaccines to enter late-stage trial by end of July, Fauci says
Dr. Fauci Warns Mutations Could Make COVID-19 More Infectious
Strong returns and supercharged investor demand drive Europe’s EMQQ past $100m milestone
2/7/20: COVID19 Update: US vs EU27
The WHO's risky communication strategy created confusion around COVID-19
2/7/20: America's Scariest Charts Updated
How to build a better Canada after COVID-19: Rethinking immigration can boost the economy
Brexit Talks – A Road to Nowhere?
U.S. coronavirus cases rise by nearly 50,000 in biggest one-day spike of pandemic
British Court Refuses To Release Venezuelan Gold To Maduro
Tampa International Airport’s quest towards a contactless passenger experience
USD/CAD muted as US jobs numbers mixed
Daily Crunch: Apple and Google block banned apps in India
Tesla to Build Mobile RNA Microfactories for CureVac’s COVID-19 Vaccine
After Gilead Reveals Remdesivir Pricing, Analyst Sees Significant Revenue Upside
Reopening the World: City leadership is fundamental to reopening the economy
Hutchins Roundup: Macroprudential policies, credit access, and more
US Open – Solid jobs report and relentless reopening optimism drive stocks and oil higher, gold and dollar slump
Stock markets rise as 4.8 million Americans back to work! What’s next?
3 “Strong Buy” Dividend Stocks Yielding Over 8%
How well is India responding to COVID-19?
Reopening America: The value of testing and modeling